Stock price when the opinion was issued
A horror show with three CEOs in the last 14 months. Even before COVID, this was in bad shape. It was oversold during the spring, but rebounded partly by June. Then the US sunbelt got hit with the second wave, which pushed down this stock. It's a tricky one. It's cheap, selling at 4x next year's estimated earnings, but estimates for it have fallen. It's a value trap. A COVID vaccine will boost this stock, but there are better ways to play the recovery (i.e. Visa or Paypal).